We serve Chemical Name:3-Morpholino-5,6-dihydropyridin-2(1H)-one CAS:545445-40-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Morpholino-5,6-dihydropyridin-2(1H)-one
CAS.NO:545445-40-7
Synonyms:5-morpholin-4-yl-2,3-dihydro-1H-pyridin-6-one
Molecular Formula:C9H14N2O2
Molecular Weight:182.22000
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.195
Index of Refraction:
PSA:45.06000
Exact Mass:182.10600
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-morpholin-4-yl-2,3-dihydro-1H-pyridin-6-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-morpholin-4-yl-2,3-dihydro-1H-pyridin-6-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-morpholin-4-yl-2,3-dihydro-1H-pyridin-6-one Use and application,5-morpholin-4-yl-2,3-dihydro-1H-pyridin-6-one technical grade,usp/ep/jp grade.
Related News: As one of the world’s largest API producers and exporters, China’s chemical API production and operating income show steady growth. 3-Morpholino-5,6-dihydropyridin-2(1H)-one manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 3-Morpholino-5,6-dihydropyridin-2(1H)-one supplier The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs. 3-Morpholino-5,6-dihydropyridin-2(1H)-one vendor In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 3-Morpholino-5,6-dihydropyridin-2(1H)-one factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.
